LEADER 05873nam a2200829 a 4500
001 2b4b8c41-7694-4ff5-bf6f-32733542eee6
005 20240926000000.0
008 100920s2010 enka ob 001 0 eng d
020 |a 1628701501  |q (electronic bk.) 
020 |a 1847559891  |q (electronic bk.) 
020 |a 9781628701500  |q (electronic bk.) 
020 |a 9781847559890  |q (electronic bk.) 
020 |z 0854041931  |q (hbk.) 
020 |z 9780854041930  |q (hbk.) 
035 |a (NNC)12174057 
035 |a (OCoLC)664556498 
035 |a (OCoLC)ocn664556498 
035 |a (Sirsi) a11842106 
035 |a (Sirsi) knocn664556498 
035 9 |a (OCLCCM-CC)664556498 
040 |a UMC  |b eng  |e pn  |c UMC  |d COO  |d CUS  |d OCLCQ  |d YDXCP  |d N$T  |d OCLCF  |d KNOVL  |d ZCU  |d OCLCQ  |d OCLCO  |d OCLCQ  |d STF  |d OCLCQ  |d AGLDB  |d OCLCQ  |d VTS  |d RRP  |d CSt 
040 |a UMC  |b eng  |e pn  |c UMC  |d COO  |d CUS  |d OCLCQ  |d YDXCP  |d N$T  |d OCLCF  |d KNOVL  |d ZCU  |d OCLCQ  |d OCLCO  |d OCLCQ  |d STF  |d OCLCQ  |d AGLDB  |d OCLCQ  |d VTS  |d RRP  |d M8D  |d OCLCQ  |d K6U  |d DKU  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCL  |d SXB  |d OCLCQ 
040 |a UMC  |b eng  |e pn  |c UMC  |d COO  |d CUS  |d OCLCQ  |d YDXCP  |d N$T  |d OCLCF  |d KNOVL  |d ZCU  |d OCLCQ  |d OCLCO  |d OCLCQ  |d STF  |d OCLCQ  |d AGLDB  |d OCLCQ  |d VTS  |d RRP  |d M8D  |d OCLCQ  |d K6U 
049 |a MAIN 
049 |a ZCUA 
050 4 |a QD415.N3  |b N38 2010 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
082 0 4 |a 615.19  |2 22 
245 0 0 |a Natural product chemistry for drug discovery /  |c edited by Antony D. Buss and Mark S. Butler 
260 |a Cambridge :  |b RSC Publishing,  |c ©2010 
300 |a 1 online resource (xvii, 440 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a RSC biomolecular sciences,  |x 1757-7136 ;  |v no. 18 
504 |a Includes bibliographical references and index 
505 0 |a Natural products as drugs and leads to drugs: The historical perspective / David J. Newman and Gordon M. Cragg -- Chemical space and the difference between natural products and synthetics / Sheo B. Singh and J. Chris Culberson -- Mechanism of action studies / James J. La Clair -- The convention on biological diversity and its impact on natural product research / Geoffrey A. Cordell -- Plants: Revamping the oldest source of medicines with modern science / Giovanni Appendino and Federica Pollastro -- Macromarines: A selective account of the potential of marine sponges, molluscs, soft corals and tunicates as a source of therapeutically important molecular structures / Jennifer Carroll and Phillip Crews -- Microorganisms: Their role in the discovery and development of medicines / Cedric Pearce, Peter Eckard, Iris Gruen-Wollny and Friedrich G. Hansske -- Advances in biological screening for lead discovery / Christian N. Parker, Johannes Ottl, Daniela Gabriel and Ji-Hu Zhang -- Advances in instrumentation, automation, dereplication and prefractionation / Tim S. Bugni, Mary Kay Harper, Malcolm W.B. McCulloch and Emily L. Whitson -- Natural product combinatorial biosynthesis: Promises and realities / Daniel W. Udwary -- A snapshot of natural product-derived compounds in late stage clinical development at the end of 2008 / Mark S. Butler -- From natural product to clinical trials: NPI-0052 (Salinosporamide A), a marine actinomycete-derived -- anticancer agent / Kin S. Lam, G. Kenneth Lloyd, Saskia T.C. Neuteboom, Michael A. Palladino, Kobi M. Sethna, Matthew A. Spear and Barbara C. Potts -- From natural product to clinical trials: Bevirimat, a plant-derived anti-AIDS drug / Keduo Qian, Theodore J. Nitz, Donglei Yu, Graham P. Allaway, Susan L. Morris-Natschke and Kuo-Hsiung Lee -- Daptomycin / Richard H. Baltz -- Micafungin / Akihiko Fujie, Shuichi Tawara and Seiji Hashimoto 
588 0 |a Print version record 
650 0 |a Biological assay 
650 0 |a Natural products 
650 0 |a Pharmacognosy 
650 2 |a Biological Assay 
650 2 |a Biological Products  |x chemistry 
650 2 |a Drug Discovery  |x methods 
650 2 |a Pharmacognosy 
650 6 |a Essais biologiques 
650 6 |a Pharmacognosie 
650 6 |a Produits naturels 
650 7 |a Biological assay  |2 fast 
650 7 |a MEDICAL  |x Drug Guides  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy  |2 bisacsh 
650 7 |a Natural products  |2 fast 
650 7 |a Pharmacognosy  |2 fast 
655 0 |a Electronic books 
655 4 |a Electronic book 
655 4 |a Electronic books 
700 1 |a Buss, Antony D 
700 1 |a Butler, Mark S 
776 0 8 |i Print version:  |t Natural product chemistry for drug discovery  |d Cambridge : RSC Publishing, ©2010  |z 9780854041930  |w (OCoLC)660502426 
830 0 |a RSC biomolecular sciences ;  |v no. 18 
830 0 |a RSC biomolecular sciences  |v no. 18 
999 1 0 |i 2b4b8c41-7694-4ff5-bf6f-32733542eee6  |l a11842106  |s US-CST  |m natural_product_chemistry_for_drug_discovery_______________________________2010_______rscpua___________________________________________________________________________e 
999 1 0 |i 2b4b8c41-7694-4ff5-bf6f-32733542eee6  |l 11283304  |s US-ICU  |m natural_product_chemistry_for_drug_discovery_______________________________2010_______rscpua___________________________________________________________________________e 
999 1 0 |i 2b4b8c41-7694-4ff5-bf6f-32733542eee6  |l 12174057  |s US-NNC  |m natural_product_chemistry_for_drug_discovery_______________________________2010_______rscpua___________________________________________________________________________e 
999 1 1 |l a11842106  |s ISIL:US-CST  |t BKS  |b 9bff7e3f-1911-577b-b8bf-804f18fd3508  |y 9bff7e3f-1911-577b-b8bf-804f18fd3508  |p UNLOANABLE 
999 1 1 |l a11842106  |s ISIL:US-CST  |t BKS  |a SUL-ELECTRONIC  |p UNLOANABLE 
999 1 1 |l 12174057  |s ISIL:US-NNC  |t BKS  |a lweb  |c EBOOKS  |p UNLOANABLE